PT - JOURNAL ARTICLE AU - Ferrari, Margaret R. AU - Schäfer, Michal AU - Hunter, Kendall S. AU - Di Maria, Michael V. TI - Application of Principal Component Analysis to Heterogenous Fontan Registry Data Identifies Independent Contributing Factors to Decline AID - 10.1101/2024.07.11.24310309 DP - 2024 Jan 01 TA - medRxiv PG - 2024.07.11.24310309 4099 - http://medrxiv.org/content/early/2024/07/12/2024.07.11.24310309.short 4100 - http://medrxiv.org/content/early/2024/07/12/2024.07.11.24310309.full AB - Single ventricle heart disease is a severe and life-threatening illness, and improvements in clinical outcomes of those with Fontan circulation have not yet yielded acceptable survival over the past two decades. Patients are at risk of developing a diverse variety of Fontan-associated comorbidities that ultimately requires heart transplant. Our observational cohort study goal was to determine if principal component analysis (PCA) applied to data collected from a substantial Fontan cohort can predict functional decline (N=140). Heterogeneous data broadly consisting of measures of cardiac and vascular function, exercise (VO2max), lymphatic biomarkers, and blood biomarkers were collected over 11 years at a single site; in that time, 16 events occurred that are considered here in a composite outcome measure. After standardization and PCA, principal components (PCs) representing >5% of total variance were thematically labeled based on their constituents and tested for association with the composite outcome. Our main findings suggest that the 6th PC (PC6), representing 7.1% percent of the total variance in the set, is greatly influenced by blood serum biomarkers and superior vena cava flow, is a superior measure of proportional hazard compared to EF, and displayed the greatest accuracy for classifying Fontan patients as determined by AUC. In bivariate hazard analysis, we found that models combining systolic function (EF or PC5) and lymphatic dysfunction (PC6) were most predictive, with the former having the greatest AIC, and the latter having the highest c-statistic. Our findings support our hypothesis that a multifactorial model must be considered to improve prognosis in the Fontan population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by the Jayden DeLuca Foundation, NIH CTSA Grant UL1 TR002535, and the American Heart Association Children?s Heart Foundation Predoctoral Congenital Heart Defect Research Award 20PRE35260057 to MRF.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Colorado Multiple Institutional Review Board (COMIRB) protocol #14-1072, approved 08/11/2023I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data that support the findings of this study are available from the corresponding author, KSH, upon reasonable requestSVDsingle ventricle diseasePLEprotein losing enteropathyPBplastic bronchitisFALDFontan-associated liver diseasePC MRIphase contrast magnetic resonance imagingVVCRventricular vascular coupling rationVO2rate of oxygen consumptionAAoascending aortaSVCsuperior vena cavaIVCinferior vena cavaLPAleft pulmonary arterycMRIcardiac MRITCPCtotal cavopulmonary connectionPCAprincipal component analysisPCsprincipal componentsEFejection fractionEDViend diastolic volume indexESViend systolic volume indexCIcardiac indexBNPB-type natriuretic peptideGGTgamma-glutamyl transferaseASTaspartate aminotransferaseSaO2arterial oxygen saturationFEV1forced expiratory volume in one secondmSVCPmean SVC pressuremPAPmean pulmonary artery pressureHLHShypoplastic left heart syndromeTAtricuspid atresiaDORVdouble outlet right ventricleDILVdouble inlet left ventricleHRHShypoplastic right heart syndromeTCPCtotal cavopulmonary circuitFVCforced vital capacityRVresidual volumeTLCtotal lung capacityAlk phosalkaline phosphataseBUNblood urea nitrogen